Monitoring cystic fibrosis lung disease in clinical trials: Is it time for a change?

Proceedings of the American Thoracic Society

Volumn 4, Issue 4, 2007, Pages 297-298

  Tiddens, Harm A W M ^a   Brody, Alan S ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; GENE THERAPY; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG VOLUME; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; RADIATION HAZARD; THORAX RADIOGRAPHY;

CLINICAL TRIALS; CYSTIC FIBROSIS; HUMANS; MONITORING, PHYSIOLOGIC;

EID: 34548228486     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200611-180HT     Document Type: Conference Paper

References (0)